- Small Animal Imaging Core The Small Animal Imaging Core (SAIC) established under the Phase I COBRE at the University of Oklahoma Health Sciences Center (OUSHC) provides access to state of the art small animal imaging modalities for evaluating tumor growth, progression, metastasis, and response to therapy. The functions of the SAIC include providing assistance, and consultation in designing in vitro and in vivo studies that involve molecular imaging. The SAIC staff's provide their expertise to the COBRE principal junior investigators (PJIs), pilot project junior investigators (PPIs), and other investigators from OUHSC and neighboring institutions with animal studies that require non-invasive molecular imaging; provide training in the use of the imaging equipment's; and subsequent collection and analysis of data. SAIC also provides assistance in optimizing imaging and other pre- and post-imaging surgical procedures. In addition, SAIC provides advanced high-content live cell imaging. Further, SAIC has developed a cell bank of human and murine cancer cell lines with molecular tags that are annotated and characterized. Using these cell lines eliminates variability in the experimental results and maintain rigor. Finally, SAIC staff's undergo annual training for software updates and other imaging-related techniques to keep them abreast of advances in imaging. During the Phase I COBRE funding period, 4 PJIs, 2 PPIs, and 89 other investigators have received service and/or training in using various equipment's and have accessed the SAIC facility for conducting their research. This has led in obtaining significant scientific data and advancing research projects resulting in conference presentations, peer-reviewed publications, and grant application submissions. Finally, SAIC has continued to expand the facility by adding new equipment's thus enabling investigators in conducting cutting-edge research. In the Phase II period, the SAIC plans continuing to train and offer assistance to new PJIs, PPISs, and other investigators in successfully conducting animal studies with ease and have rigor and reproducibility. For achieving these objectives, SAIC has identified three specific aims ? 1) provide service, assistance, and consultation in designing in vitro and in vivo studies related to molecular imaging; 2) provide labeled cells for monitoring gene expression, cell trafficking, and disease progression in in vitro and in vivo models; 3) Assist in high-throughput and high- content imaging of live cells and in imaging of tumor xenografts and other tissues. Continued availability of SAIC services will allow PJIs, PPIs, and other investigators in generating preliminary data for submitting grant applications and obtaining research funding.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Exploratory Grants (P20)
Project #
2P20GM103639-06A1
Application #
9573535
Study Section
Special Emphasis Panel (ZGM1)
Project Start
Project End
Budget Start
2018-07-01
Budget End
2019-06-30
Support Year
6
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Oklahoma Health Sciences Center
Department
Type
DUNS #
878648294
City
Oklahoma City
State
OK
Country
United States
Zip Code
73104
Liu, Xuan; Shen, Tao; Mooers, Blaine H M et al. (2018) Drug resistance profiles of mutations in the RET kinase domain. Br J Pharmacol 175:3504-3515
Boswell-Casteel, Rebba C; Johnson, Jennifer M; Hays, Franklin A (2018) Functional Characterization of the Saccharomyces cerevisiae Equilibrative Nucleoside Transporter 1 (ScENT1). Molecules 23:
Jaiprasart, Pharavee; Yeung, Bertrand Z; Lu, Ze et al. (2018) Quantitative contributions of processes by which polyanion drugs reduce intracellular bioavailability and transfection efficiency of cationic siRNA lipoplex. J Control Release 270:101-113
Buechel, Megan; Dey, Anindya; Dwivedi, Shailendra Kumar Dhar et al. (2018) Inhibition of BMI1, a Therapeutic Approach in Endometrial Cancer. Mol Cancer Ther 17:2136-2143
Ha, Ji Hee; Radhakrishnan, Rangasudhagar; Jayaraman, Muralidharan et al. (2018) LPA Induces Metabolic Reprogramming in Ovarian Cancer via a Pseudohypoxic Response. Cancer Res 78:1923-1934
Dey, Anindya; Xiong, Xunhao; Crim, Aleia et al. (2018) Evaluating the Mechanism and Therapeutic Potential of PTC-028, a Novel Inhibitor of BMI-1 Function in Ovarian Cancer. Mol Cancer Ther 17:39-49
Boswell-Casteel, Rebba C; Johnson, Jennifer M; Roe-Žurž, Zygy et al. (2018) Expression and purification of human and Saccharomyces cerevisiae equilibrative nucleoside transporters. Protein Expr Purif 142:68-74
Jiao, Yang; Watts, Tanya; Xue, Jing et al. (2018) Sorafenib and docosahexaenoic acid act in synergy to suppress cancer cell viability: a role of heme oxygenase 1. BMC Cancer 18:1042
Sun, X; Ren, Y; Gunawan, S et al. (2018) Selective inhibition of leukemia-associated SHP2E69K mutant by the allosteric SHP2 inhibitor SHP099. Leukemia 32:1246-1249
Amreddy, Narsireddy; Babu, Anish; Panneerselvam, Janani et al. (2018) Chemo-biologic combinatorial drug delivery using folate receptor-targeted dendrimer nanoparticles for lung cancer treatment. Nanomedicine 14:373-384

Showing the most recent 10 out of 68 publications